Participants initiating ART with CD4 counts below 100 cells/mm3 are started on concomitant prednisone (40 mg for 14 days then 20 mg for the next 14 days) for prevention of paradoxical TB-IRIS in line with findings of the PredART trial [40]. Here, CD4 is linked to tuberculosis.